Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
about
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology GroupOsteonecrosis in children with acute lymphoblastic leukemiaPharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyDexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trialFactors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.Interactions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes.Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatmentHow does osteonecrosis about the knee progress in young patients with leukemia?: a 2- to 7-year study.Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT.Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.Impairments that influence physical function among survivors of childhood cancerRole of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivorsMedical and psychosocial associates of nonadherence in adolescents with cancer.Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature.NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Glucocorticoid use in acute lymphoblastic leukaemiaOsteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging.Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse ModelMultimodality treatment of a complex series of parallel pathologies in a 16-year-old male that ultimately leads to bilateral hip arthroplasty surgery: A case reportOsteonecrosis of the femoral head: diagnosis and classification systems.Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemiaEffect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trialAggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemiaWidespread osteonecrosis in children with leukemia revealed by whole-body MRI.Long-term complications of therapeutic exposures in childhood: lessons learned from childhood cancer survivors.Oncological imaging: tumor surveillance in childrenOsteonecrosis in children after therapy for malignancy.Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia.Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupSurvivor typologies predict medical surveillance participation: the childhood cancer survivor studyGenetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.Survivor profiles predict health behavior intent: the Childhood Cancer Survivor StudyOsteonecrosis of the femoral head in childhood malignancy.Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institut
P2860
Q24656610-3F52B388-8185-4E11-BAA9-063540CE4BD9Q28066799-049295AC-3268-4195-9758-9A585D497237Q28083449-59DB16A3-D3F9-4036-8BBD-768F6DCA2AEEQ33828580-2F3F0496-715B-45C0-9C88-129942B11FEFQ33857860-8A025BDB-94C0-40F5-A2DE-0AF9E7FF7DA2Q33959230-CC946D33-7FB2-4B0B-B7FD-600ECCD7128EQ34003323-D329013A-291F-4417-960C-63CD52BF3CB9Q34038283-92A69EB8-D863-447A-998E-5591C4B8946CQ34058996-81603F48-64CA-4F06-91AF-3DBE57287829Q34440965-57C7F4FF-EF80-48C0-A87E-3D75639EB76CQ34550540-8F8B7FC7-4925-4277-AC57-A2524AF502D4Q34707586-38971AB0-7726-47A6-9113-E168E9AC4581Q35065477-6F6FA855-273A-4933-80C3-98A141C430E8Q35082766-DB0A7542-5A90-4A45-8B1B-CC3B0A7EE90AQ35327266-1ED33613-E37A-437B-9824-2B587CE790AAQ35540284-E052EE14-DD4C-4632-A432-568322E0D9D8Q35555709-F3C5D521-7048-4100-8B46-EF382D58FB38Q35563274-25FE7B94-599F-49CC-87C2-E5BE24E26CA9Q35740019-1592834A-64FD-4968-843C-2F5A71CFB5A3Q35815806-68A5095C-954F-4498-96E6-AF6C6394E62DQ35844745-0E034AD2-7FCA-429D-9869-DDCB56DC85B0Q35846626-8CD4D2B8-7941-4643-BD2D-0A631416677DQ35925012-3AB32CED-6876-4D27-9045-8FF921589572Q35954058-BFE681D0-7193-4B6D-8B5A-E24DA838DFB7Q36037429-E76119EE-EBD4-488B-ACDF-5FAD759FB9E6Q36130380-323930E8-3900-435E-A5AE-0AFCD6D5A97AQ36143232-68D3DCA8-5758-4248-9B18-5657B62214E4Q36251056-77F0C9EA-1D97-4E06-8DA7-E01F351A772AQ36337592-EF9BA75C-2BB8-4443-9AC2-650010CFE9B5Q36381725-AA3959C8-2748-4B39-A287-10CE5ECEBC6CQ36425784-C27353CF-3159-40E5-AAE8-A966566FB7E4Q36429322-001A95BA-3BCF-4207-82D0-2B273C9C9C20Q36429353-56270ACF-83F4-4686-B79C-E6CB45FE4061Q36452241-EC93772C-AE04-4577-992C-B92D048B7738Q36478435-CD89CF5F-87F0-4AA4-9BA4-8808D71DF2CBQ36542308-AEC502D5-2BC2-4231-8801-F4F8632D7633Q36547791-312986BE-8AC5-499B-9609-B200B7D7BC47Q36584433-C0336E77-2256-4E0D-88E0-1F1AE4BF210CQ36670407-E5A53687-78C0-46A3-B7EE-572BAEEE1087Q36678136-F6DA3721-5253-463B-930C-7C1C4A54BA51
P2860
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Osteonecrosis as a complicatio ...... m the Children's Cancer Group.
@en
type
label
Osteonecrosis as a complicatio ...... m the Children's Cancer Group.
@en
prefLabel
Osteonecrosis as a complicatio ...... m the Children's Cancer Group.
@en
P2093
P1476
Osteonecrosis as a complicatio ...... m the Children's Cancer Group.
@en
P2093
H N Sather
J B Nachman
L A Mattano
P304
P356
10.1200/JCO.2000.18.18.3262
P407
P577
2000-09-01T00:00:00Z